Investment Banking

Home » Services » Individual Investors

Our goal is to enable quick, efficient transactions – regardless of business or technology complexity – and remain a partner after closing with continuous support.

As a full-service investment bank, we partner with companies across a wide range of industries — combining market insight and sector expertise in healthcare, biotechnology, technology, and clean tech. By investing the time to fully understand your business, we provide appropriate capital transaction structures and strategies, helping craft the vision and message for the capital markets.

See also: Research | Capital Markets | Institutional Sales & Trading

Diversified Investor OfferingTM (DIO)

Our DIO strategy provides a combination of capital market benefits that can enhance competitive pricing in equity financing and potentially support a stronger share price at issuance. DIO delivers customized, concurrent access to both retail and institutional investors and positions the issuer for the best offering terms depending on where stronger interest exists. By targeting a larger number of investors (vs. a small number of institutions), the process can increase the number of trading shareholders and may help issuers meet requirements to uplist to a higher exchange.

Team

Robert D. Keyser Jr. Chief Executive Officer
Carlo Corzine Investment Banking Principal
Robert D. Keyser, III Managing Director – Head of Capital Markets
Cory Wachowiz Managing Director of Investment Banking

  • Corporate Finance Capabilities
  • Offerings | Follow-ons | IPOs | Secondaries | Rights
  • Strategic Advisory | Buy-side / Sell-side advisory | Restructuring
  • Valuations / Fairness opinions
  • Private Placements
  • Common stock / Convertible notes | Registered directs | Preferred stock
  • Units (common stock / warrants) | Bridge loans | PIPEs
Contact

Investmentbanking@dawsonjames.com
Info@dawsonjames.com

Recent Investment Banking Transactions

February 25, 2026

T3 Defense Inc.

$20,000,000

Acted as Placement Agent

February 12, 2026

RenX Enterprises Corp. (f/k/a Safe and Green)

$6,000,000

Acted as Placement Agent

February 5, 2026

Aspire Biopharma Holding, Inc.

$20,000,000

Acted as Placement Agent